H&F Corporate Investors X
Latest statistics and disclosures from H&F Corporate Investors X's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDLN, and represent 100.00% of H&F Corporate Investors X's stock portfolio.
- Reduced shares in these 1 stock: MDLN (-$580M).
- H&F Corporate Investors X was a net seller of stock by $-580M.
- H&F Corporate Investors X has $3.8B in assets under management (AUM), dropping by -7.93%.
- Central Index Key (CIK): 0001901930
Tip: Access up to 7 years of quarterly data
Positions held by H&F Corporate Investors X consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for H&F Corporate Investors X
H&F Corporate Investors X holds 1 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medline Com Cl A (MDLN) | 100.0 | $3.8B | -13% | 87M | 44.50 |
|
Past Filings by H&F Corporate Investors X
SEC 13F filings are viewable for H&F Corporate Investors X going back to 2022
- H&F Corporate Investors X 2026 Q1 filed May 11, 2026
- H&F Corporate Investors X 2025 Q4 filed Feb. 13, 2026
- H&F Corporate Investors X 2025 Q3 filed Nov. 12, 2025
- H&F Corporate Investors X 2025 Q2 filed Aug. 12, 2025
- H&F Corporate Investors X 2025 Q1 filed May 13, 2025
- H&F Corporate Investors X 2024 Q4 filed Feb. 12, 2025
- H&F Corporate Investors X 2024 Q3 filed Nov. 13, 2024
- H&F Corporate Investors X 2024 Q2 filed Aug. 14, 2024
- H&F Corporate Investors X 2024 Q1 filed May 13, 2024
- H&F Corporate Investors X 2023 Q3 filed Nov. 13, 2023
- H&F Corporate Investors X 2023 Q2 filed Aug. 11, 2023
- H&F Corporate Investors X 2023 Q1 filed May 4, 2023
- H&F Corporate Investors X 2022 Q4 filed Jan. 30, 2023
- H&F Corporate Investors X 2022 Q3 filed Nov. 14, 2022
- H&F Corporate Investors X 2022 Q2 filed Aug. 9, 2022
- H&F Corporate Investors X 2022 Q1 filed May 16, 2022